Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10. (2021)
Attributed to:
Cambridge Confidence in Concepts: translating pathophysiological insights for patient benefit
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.peptides.2020.170440
PubMed Identifier: 33171278
Publication URI: http://europepmc.org/abstract/MED/33171278
Type: Journal Article/Review
Volume: 136
Parent Publication: Peptides
ISSN: 0196-9781